30 Tablets (Lamotrigine 200)
Lamotrigine Tablet, Extended Release
Product Images NDC 46708-418
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 46708-418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
30 Tablets (Lamotrigine 250)
30 Tablets (Lamotrigine 300)
Lamotrigine Description (Lamotrigine Description 1)
This is a description of different types of pills: a 200 mg blue pill, a 250 mg purple pill, and a 300 mg grey pill. The pills are imprinted with codes "A196," "A197," and "A198."*
Figure 1 (Lamotrigine Figure1)
Figure 2 (Lamotrigine Figure2)
The text provides information on the Responder Rate, Improvement, and Worsening for Placebo (N=120) and Lamotrigine Extended-Release Tablets (N<116). It also shows that the Responder Rate for both groups is set at 100%.*
Structure (Lamotrigine Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
